Articles

Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care, associate editor of Evidence-Based Oncology, and vice president of the Community Oncology Alliance, discusses his new book. 

When the Topic Is Dying: A Conversation With Kashyap Patel, MD

An HHS report outlines efforts to reduce kidney failure and increase options such as home-based dialysis. COVID-19 has made kidney care a higher priority. 

Administration Offers Progress Report on Kidney Care Initiative

In a webinar, experts outlined challenges providers face amid the coronavirus disease 2019 (COVID-19) pandemic and the benefits of increased access to high-value care during the outbreak and beyond. 

Experts Argue COVID-19 Provides Opportunity to Implement Value-Based Care Practices

What Netflix Can Teach Us About Investing in the Provider Experience

A study looking at the ways in which different countries handle appraisal and reimbursement processes for rare disease treatments (RDTs) revealed that implementing supplemental processes can aid in patient and physician decision making.

Supplemental Process Can Aid in Assessing Value of Rare Disease Treatments

Videos

In addressing the COVID-19 pandemic, a more active-based approach is warranted among employers to optimize care. Through detailed databases and a greater focus on population health, Paladina Health has promoted this transition to a more informed, value-based health care delivery system, said Kirk Rosin, chief revenue officer of Paladina Health.

How Can Integrating Data, Population Health Optimize Employer Health Care Delivery Amid COVID-19?

Expanding Treatment Options for Metastatic Breast Cancer

Technology has made it easier to deliver health care in the home in recent years, but the financing models have not caught up just yet.

Is Home Care Going Mainstream in the United States?

The American Society of Hematology has adopted 10 of the recommendations from Choosing Wisely to encourage more high-value care, but barriers to adoption remain.

What Are the Barriers to Choosing Wisely in Hematology Care?

Administrator Seema Verma said the proposal would create opportunities "for drug manufacturers to have skin in the game through payment arrangements that challenge them to put their money where their mouth is."

IVBM

New content coming soon, please check back later.